Your browser doesn't support javascript.
loading
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer.
Yi, Yali; Cai, Jing; Xu, Peng; Xiong, Le; Lu, Zhiqin; Zeng, Zhimin; Liu, Anwen.
Afiliación
  • Yi Y; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi province, China.
  • Cai J; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi province, China.
  • Xu P; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi province, China.
  • Xiong L; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi province, China.
  • Lu Z; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi province, China.
  • Zeng Z; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi province, China.
  • Liu A; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi province, China.
J Transl Med ; 20(1): 122, 2022 03 14.
Article en En | MEDLINE | ID: mdl-35287683
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China